Test Price
2,800 AED✅ Home Collection Available
WDR62 Gene Microcephaly with Cortical Malformations, Autosomal Recessive Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين WDR62 لصغر الرأس مع التشوهات القشرية، النمط الجسدي المتنحي من النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: يقدم هذا الفحص الجيني الشامل تشخيصًا دقيقًا لمتلازمة صغر الرأس من النوع الثاني المرتبط بجين WDR62، ويتم وفقًا لأعلى المعايير الإكلينيكية والقانونية في دولة الإمارات العربية المتحدة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation from our DHA-licensed experts.
- Insurance & Licensing: Direct Billing Verification via WhatsApp +971 54 548 8731 | DHA Facility License: 9834453.
Overview
This NGS-based genetic test examines the entire WDR62 gene to identify pathogenic variants causing autosomal recessive primary microcephaly type 2 with cortical malformations, enabling definitive molecular diagnosis and informed clinical management.
يقوم هذا التحليل بتسلسل كامل لجين WDR62 باستخدام تقنية الجيل التالي، مما يوفر تشخيصًا وراثيًا دقيقًا لاضطراب صغر الرأس والتشوهات القشرية.
| Parameter | Our Test (ISO 9001:2015) | Closest Alternative |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) with full gene coverage, including intron-exon boundaries | Targeted Sanger sequencing (single exon) or chromosomal microarray (no gene-level resolution) |
| Diagnostic Sensitivity | >99.9% for single nucleotide variants and small indels within WDR62 | ~85% (microarray) or limited to known hotspots |
| Turnaround Time | 3 to 4 Weeks | 4-6 Weeks (may require reflex testing) |
| Sample Flexibility | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | Often restricted to whole blood |
Physician Insight & Safety Protocol
“A confirmed genetic diagnosis of WDR62-related microcephaly brings clarity to families and guides neurodevelopmental support, surveillance for cortical dysplasia, and recurrence risk counseling. We emphasize that results must be interpreted in the context of detailed brain imaging and clinical findings. Our multidisciplinary team stands with you throughout the diagnostic journey.”
— Dr. PRABHAKAR REDDY, DHA-Licensed Consultant Pediatrician (License: 61713011)
⚠️ Medication Alert: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Patients with active high fever, severe respiratory distress, or hemodynamic instability should postpone home collection and seek immediate medical attention.
- If the child experiences new-onset seizures, altered consciousness, or signs of raised intracranial pressure (bulging fontanelle, forced downward gaze), proceed to the nearest emergency department.
- Sample collection must be performed by our certified phlebotomist; self-collection is not permitted for infants.
Patient FAQ & Clinical Guidance
1. What is the WDR62 gene test and who should consider it?
This genetic test uses next-generation sequencing to detect WDR62 mutations causing autosomal recessive microcephaly type 2. It is clinically indicated for newborns and infants presenting with severe congenital microcephaly (head circumference < -3 SD), cortical malformations on neuroimaging, and a family history suggesting recessive inheritance. Pediatricians, neonatologists, and clinical geneticists are the primary specialists who order this test after thorough clinical and radiological evaluation.
هذا الاختبار الجيني بتقنية التسلسل المتقدم يكشف الطفرات في جين WDR62 المسببة لصغر الرأس الوراثي من النوع الثاني، ويُنصح بإجرائه للرضع الذين يعانون من صغر رأس شديد مع تشوهات قشرية في الرنين المغناطيسي.
2. How is the sample collected and how long do results take?
A small blood sample, extracted DNA, or a dried blood spot on an FTA card is collected at home. Our VIP mobile phlebotomy team arrives at your preferred time (8 AM – 11 PM) and ensures cold-chain transport to our ISO-certified laboratory. The turnaround time is 3 to 4 weeks. A completed clinical history form and a pedigree chart from a genetic counseling session must accompany the sample.
يتم جمع العينة في المنزل عبر فريق تمريض متنقل معتمد، وتُحفظ في سلسلة تبريد معتمدة، وتظهر النتائج خلال ٣ إلى ٤ أسابيع مع ضرورة إرفاق التاريخ السريري وشجرة العائلة.
3. Is this covered by insurance in UAE?
Most UAE insurance plans cover medically necessary genetic testing for congenital anomalies when preauthorized by a pediatric neurologist or geneticist. We verify your direct billing eligibility and handle approvals prior to collection. Contact our support team on WhatsApp at +971 54 548 8731; we respond within minutes to provide a confirmation of your coverage and out-of-pocket estimate.
تغطي معظم خطط التأمين في الإمارات الفحوصات الجينية الضرورية طبيًا بعد الحصول على موافقة مسبقة، ويتولى فريقنا التحقق من الأهلية وإجراءات الموافقة عبر واتساب على الرقم +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians